Autophagy dysregulation plays a crucial role in regulatory T-cell loss and neuroinflammation in amyotrophic lateral sclerosis (ALS)
- 1 November 2023
- journal article
- research article
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Vol. 25 (3-4) , 336-344
Abstract
Objective: Neuroinflammation is the hallmark of amyotrophic lateral sclerosis (ALS) disease. Regulatory T cells (Tregs) are essential in immune tolerance and neuroinflammation prevention. It has been shown that a significant decrease in Treg and FoxP3 protein expression is observed in ALS patients. The main reason for the FoxP3(+) Treg loss in ALS is unknown. In this study, the role of autophagy dysregulation in FoxP3(+) Tregs in ALS was investigated.Methods: Twenty-three ALS patients and 24 healthy controls were recruited for the study. Mononuclear cells (MNCs) were obtained from peripheral blood, and then Tregs were isolated. Isolated Tregs were stained with FoxP3 and LC3 antibodies and analyzed in flow cytometry to determine autophagy levels in FoxP3(+) Tregs in patients and controls.Results: The mean of FoxP3(+) LC3(+) cells, were 0.47 and 0.45 in patients and controls, respectively. The mean of FoxP3(+) LC3- cells was 0.15 in patients and 0.20 in controls, p = 0.030 (p < 0.05). There is no significant correlation between ALSFRS-R decay rate and autophagy level in patients. Also, there is no significant difference between autophagy levels in FoxP3(+) Tregs in patients with rapidly progressing ALS and slow-progressing ALS.Conclusion: Excessive autophagy levels in FoxP3(+) Tregs in ALS patients can potentially be an explanation for an increased cell death and result in worsened neuroinflammation and disease onset. However, the disease progress is not attributable to autophagy levels in FoxP3(+) Tregs.Keywords
This publication has 34 references indexed in Scilit:
- Immune Privilege as an Intrinsic CNS Property: Astrocytes Protect the CNS against T-Cell-Mediated NeuroinflammationMediators of Inflammation, 2013
- Regulatory T‐lymphocytes mediate amyotrophic lateral sclerosis progression and survivalEMBO Molecular Medicine, 2012
- A proposed staging system for amyotrophic lateral sclerosisBrain, 2012
- Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in miceImmunology & Cell Biology, 2010
- Oxidized Low-density Lipoprotein-induced Proinflammatory Cytokine Response in Macrophages are Suppressed by CD4+CD25+Foxp3+ Regulatory T Cells Through Downregulating Toll Like Receptor 2-mediated Activation of NF-ĸBCellular Physiology and Biochemistry, 2010
- Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored?Immunology, 2008
- Molecular biology of amyotrophic lateral sclerosis: insights from geneticsNature Reviews Neuroscience, 2006
- Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple SclerosisJournal of Experimental Medicine, 2004
- Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000Journal of Neurology, Neurosurgery & Psychiatry, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003